Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ranitidine
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- H2-receptor antagonists
- ATC
- A02BA
- Strength
- 300 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 053159
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Maple Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 298.64 to 313.39 (+4.9%) between 4 Nov 2025 and 17 Aug 2026 · 2 official price records · pack 10's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. CURASOFT-EFF 300 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/curasoft-eff-300-mg-053159-10s-maple-pharmaceuticals-pvt-ltd/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 313.39 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 298.64 | 2025-11-04 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 053159Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
